Koers Aerie Pharmaceuticals, Inc.
Aandelen
AERI
US00771V1089
Farmaceutische producten
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Endicott
CEO | Chief Executive Officer | 58 | 21-11-22 |
Andrew Allen
CMP | Compliance Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 01-03-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ian Bell
BRD | Director/Board Member | 54 | 21-11-22 |
Chairman | 57 | 21-11-22 | |
Jonathan Balch
BRD | Director/Board Member | - | 21-11-22 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.02% | 464 M€ | -.--% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,50% | 701 mld. | |
+26,24% | 571 mld. | |
+0,78% | 381 mld. | |
+20,85% | 334 mld. | |
+16,38% | 319 mld. | |
+2,79% | 210 mld. | |
+1,04% | 210 mld. | |
-6,75% | 201 mld. | |
-3,51% | 157 mld. |